Insider trading · Q3 2026 · CIK 1561921

TELA Bio, Inc. (TELA) insider trading.

In Q3 2026, insiders at TELA Bio, Inc. reported 9 non-derivative transactions on 8 Forms 3, 4 and 5: 6 open-market purchases worth $186K and 0 sales.

Transactions
9
Purchases (P)
6
Sales (S)
0
Net shares, P minus S
177,500
Insiders
3
Last filed
2026-09-18

Insiders

InsiderRelationshipTransactionsBuysSales
Capper Joseph HDirector540
Getz Heather CDirector, Officer · Chief Executive Officer320
Plovanic William J.Director100

Transactions

9 non-derivative rows, newest transaction first. Shares and prices as filed.
DateInsiderCodeSharesPriceOwned afterFiling
2026-09-17Capper Joseph HP (A)25,000$1.22179,827Form 4
2026-09-16Capper Joseph HP (A)50,000$1.17154,827Form 4
2026-09-15Capper Joseph HP (A)50,000$1.06104,827Form 4
2026-09-14Capper Joseph HP (A)25,000$1.0254,827Form 4
2026-08-17Getz Heather CP (A)12,500$0.66532,500Form 4
2026-08-14Getz Heather CP (A)15,000$0.7520,000Form 4
2026-08-03Getz Heather CA (A)500,000$0505,000Form 4
2026-07-15Capper Joseph HA (A)6,227$0.7929,827Form 4
2026-07-15Plovanic William J.A (A)20,930$0.7944,530Form 4

Transaction codes in this quarter

Get TELA insider transactions through the API

Request with your API key
curl "https://sec-api.dev/api/v1/insider-transactions?period=2026q3&cik=1561921&limit=100" \
  -H "Authorization: Bearer $SEC_API_KEY"

Insider trading API guide · TELA company page · TELA Bio, Inc. on SEC.gov

Questions

Are insiders buying or selling TELA Bio, Inc. (TELA)?

In Q3 2026, insiders at TELA Bio, Inc. reported 9 non-derivative transactions on 8 Forms 3, 4 and 5: 6 open-market purchases worth $186K and 0 sales. Grants, tax withholding and option exercises are counted as transactions but are not purchases or sales.

Where do these TELA Bio, Inc. insider trades come from?

From the SEC Insider Transactions Data Sets for Q3 2026, which republish the Forms 3, 4 and 5 filed on EDGAR. Each row links to its filing on SEC.gov.

Source: SEC Insider Transactions Data Sets, Q3 2026, retrieved 2026-10-27. Footnotes, derivative holdings and amendments are in the linked filings. Not investment advice.

Plain-text version for agents and LLMs: /insider-trading/tela.md

Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.